Follow
Teresa Bernal Del Castillo
Teresa Bernal Del Castillo
Servicio de Hematología y Hemoterapia. Hospital Universitario Central de Asturias
Verified email at uniovi.es
Title
Cited by
Cited by
Year
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts
H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ...
Blood, The Journal of the American Society of Hematology 126 (3), 291-299, 2015
12912015
Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
AR Folgueras, FM de Lara, AM Pendás, C Garabaya, F Rodríguez, ...
Blood, The Journal of the American Society of Hematology 112 (6), 2539-2545, 2008
3492008
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
MD Cappellini, J Porter, A El-Beshlawy, CK Li, JF Seymour, M Elalfy, ...
haematologica 95 (4), 557, 2010
3422010
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group
A Oriol, S Vives, JM Hernández-Rivas, M Tormo, I Heras, C Rivas, ...
Haematologica 95 (4), 589, 2010
3252010
Cytogenetic risk stratification in chronic myelomonocytic leukemia
E Such, J Cervera, D Costa, F Solé, T Vallespí, E Luño, R Collado, ...
Haematologica 96 (3), 375, 2011
3012011
Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome
G Sanz, B Nomdedeu, E Such, T Bernal, M Belkaid, MT Ardanaz, V Marco, ...
Blood 112 (11), 640, 2008
1652008
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
CM Santamaría, MC Chillón, R García-Sanz, C Perez, MD Caballero, ...
Blood, The Journal of the American Society of Hematology 114 (1), 148-152, 2009
1312009
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
H Döhner, A Dolnik, L Tang, JF Seymour, MD Minden, RM Stone, ...
Leukemia 32 (12), 2546-2557, 2018
1172018
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T Bernal, P Martínez-Camblor, J Sánchez-García, R de Paz, E Luño, ...
Leukemia 29 (9), 1875-1881, 2015
1042015
Ventilatory support in critically ill hematology patients with respiratory failure
R Molina, T Bernal, M Borges, R Zaragoza, J Bonastre, RM Granada, ...
Critical Care 16, 1-7, 2012
1032012
Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents
S Park, JF Hamel, A Toma, C Kelaidi, S Thépot, MD Campelo, V Santini, ...
Journal of Clinical Oncology 35 (14), 1591-1597, 2017
992017
Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors
RG Urdinguio, AF Fernandez, A Moncada-Pazos, C Huidobro, ...
Cancer research 73 (1), 395-405, 2013
892013
Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study …
JM Ribera, O García, C Grande, J Esteve, A Oriol, J Bergua, ...
Cancer 119 (9), 1660-1668, 2013
862013
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
JF Seymour, H Döhner, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ...
BMC cancer 17, 1-13, 2017
732017
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
CM Santamaría, MC Chillón, R García-Sanz, C Pérez, MD Caballero, ...
Leukemia research 33 (12), 1706-1709, 2009
682009
The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia
C Santamaría, M Chillón, R García-Sanz, A Balanzategui, ME Sarasquete, ...
Ferrata Storti Foundation, 2008
662008
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
C Santamaría, MC Chillón, R García-Sanz, C Pérez, MD Caballero, ...
Annals of hematology 89, 453-458, 2010
642010
Effects of thinning on litterfall were found after years in a Pinus halepensis afforestation area at tree and stand levels
FB Navarro, A Romero-Freire, T Del Castillo, A Foronda, MN Jiménez, ...
Forest Ecology and Management 289, 354-362, 2013
572013
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a …
J Briones, S Novelli, JA García-Marco, JF Tomás, T Bernal, C Grande, ...
haematologica 99 (3), 505, 2014
562014
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a …
J Briones, S Novelli, JA García-Marco, JF Tomás, T Bernal, C Grande, ...
haematologica 99 (3), 505, 2014
562014
The system can't perform the operation now. Try again later.
Articles 1–20